Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH
Status:
Unknown status
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate that the tranexamic acid (TXA)Intravenous and oral,
is equivalent oxytocin (OXY),intramuscularly, in reducing the blood loss in post partum
period (mL) in patients at the end of pregnancy ( 37-42 w ) at low risk of post partum
hemorrhage (PPH). The PPH means a blood loss equal to or greater than 500 ml after a vaginal
delivery (the bleeding is defined severe if it exceeds 1000 mL). PPH is called "primary" when
blood loss arose within 24 hours after birth.